• OPEN AN ACCOUNT
Indian Indices
Sensex
79,116.19 -1,122.66
( -1.40%)
Global Indices
Nasdaq
48,521.56 -404.23
(-0.83%)
Dow Jones
6,836.74 -65.88
(-0.95%)
Hang Seng
54,115.64 -2,163.41
(-3.84%)
Nikkei 225
10,568.52 84.39
(0.80%)
Forex
USD-INR
91.48 0.43
(0.47%)
EUR-INR
107.28 -0.27
(-0.25%)
GBP-INR
122.62 -0.09
(-0.07%)
JPY-INR
0.58 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Aurionpro Solutions Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
532668
INE132H01018
194.749879
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AURIONPRO
42.71
4732.06
EPS(TTM)
Face Value()
Div & Yield %
20.05
10
0.4
 

infobeans technologies ltd
Aarti Drugs gains as arm incorporates step-down subsidiary in Chile
Mar 04,2026
With this incorporation, Tripharma Chile SpA becomes a step-down subsidiary of Aarti Drugs. The newly formed entity has been established to market formulation drugs and participate in government tenders as well as the private pharmaceutical market in Chile. The business activities of the new subsidiary are aligned with those of its holding companies.

The cost of subscription stands at 1,000,000 Chilean pesos towards share capital contribution, comprising 1,000,000 shares. The entire share capital of Tripharma Chile SpA will be held by Pinnacle Chile SpA, making it a wholly owned step-down subsidiary of the company.

Aarti Drugs was established in the year 1984 and forms part of the $6 billion Aarti Group of Industries. The company is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates and speciality chemicals and produces formulations with its wholly-owned subsidiary, Pinnacle Life Science.

The company reported a 9.4% increase in consolidated net profit to Rs 40.54 crore on an 8.1% rise in net sales to Rs 601.71 crore in Q3 FY26 as compared with Q3 FY25.